Early scans reveal prostate radiotherapy toxicity risk
Daily scans taken during prostate cancer radiotherapy could be repurposed to guide changes to treatment, reducing the risk…
Emmy winner John Tesh opens up about cancer battle, credits wife Connie Sellecca for saving his life
Veteran musician and television personality John Tesh has spoken candidly about his long and difficult journey with prostate…
Understanding metastatic prostate cancer in men over 70: Know how to detect and modern treatment options that can extend life |
Screening for prostate cancer becomes more complex in men over the age of 70. The US Preventive Services…
Curcumin in prostate cancer: a systematic review of molecular mechanisms and nanoformulated therapeutic strategies | BMC Cancer
Curcumin, a dietary polyphenol derived from Curcuma longa, has been extensively studied for its pleiotropic biological activities, particularly…
Cancer-related identity and advanced old age – analysis of prostate cancer survivors after radical prostatectomy over the age of 75 | BMC Geriatrics
Many men affected by PCa reach an age beyond 75 after initial cancer treatment. Nevertheless, the diagnosis of…
Genetic risk scores fail to predict survival after diagnosis
New research across seven global biobanks shows that the DNA driving disease onset does not determine survival; instead,…
Diagnostic Imaging's Weekly Scan: September 21 — September 27 – diagnosticimaging.com
Diagnostic Imaging’s Weekly Scan: September 21 — September 27 diagnosticimaging.comMedical imaging radiation linked to small cancer risk in children News-MedicalCT…
Pfizer Highlights Momentum in Redefining Standards of Care in Cancer at ESMO 2025
More than 45 abstracts, including five late-breaking presentations and recognition in Presidential Symposium, showcase impact of approved medicines…
New T cell therapy targets CTNNB1 cancer mutation with promising results in animal studies
Researchers at the University of Oslo and Oslo University Hospital have developed a promising new immunotherapy targeting the…
Prostate Cancer Breakthroughs With Nuclear Medicine
KUALA LUMPUR, Sept 25 — When a 72-year-old patient found himself unable to enjoy even the simplest pleasures,…
Genomic testing speeds patient accrual in high-risk prostate cancer trial
The NRG Oncology NRG-GU009 (PREDICT-RT) study evaluating intensified and de-intensified concurrent radiation regimens based on the genomic risk…
Oncologist says ‘men over 50’ should never ignore these early warning signs of prostate cancer
Men’s health often takes a backseat until symptoms become hard to ignore. Ignoring early signs can have serious…